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Background: International phytosanitary standards ISPM 15 require (since 2007) fumigation or heat treatment for
shipping and storage. Those dealing with fumigated freight might be accidentally exposed. In this paper we report
a series of three accidents of six storage room workers in a medium sized company regularly importing electronic
production parts from abroad.
Methods: Patients (n = 6, aged from 32–54 yrs.) and control group (n = 30, mean 40 yrs.) donated blood and urine
samples. The fumigants: ethylene oxide, methyl bromide, chloropicrin, ethylene dichloride, other halo-alkanes and
solvents were analyzed by headspace gas chromatography/mass spectrometry (GCMS). For the quantitation of long term
exposure/s, macromolecular reaction products (hemoglobin adducts) were used (with GCMS) as molecular dosimeter;
additionally 8-OHdG and circulating mtDNA (cmtDNA) were analyzed as nonspecific biological effect markers.
Results: The hemoglobin adducts N-methyl valine (MEV) and N-(2-hydroxy ethyl) valine (HEV) were elevated after
exposure to the alkylating chemicals methyl bromide and ethylene oxide. Under the consideration of known
elimination kinetics and the individual smoking status (biomonitored with nicotine metabolite cotinine and tobacco
specific hemoglobin adduct: N-(2 cyan ethyl) valines, CEV), the data allow theoretical extrapolation to the initial protein
adduct concentrations at the time of the accident (the MEV/CEV levels were from 1,616 pmol/g globin to 1,880 pmol/g
globin and HEV/CEV levels from 1,407 pmol/g globin to 5,049 pmol/g globin, and correlated with inhaled 0.4-1.5 ppm
ethylene oxide. These integrated, extrapolated internal doses, calculated on the basis of biological exposure equivalents,
confirmed the clinical diagnosis for three patients, showing severe intoxication symptoms. Both, cmtDNA and 8-OHdG, as
non-specific biomarkers of toxic effects, were elevated in four patients.
Conclusion: The cases reported here, stress the importance of a suitable risk assessment and control measures. We put
emphasis on the necessity of human biomonitoring guidelines and the urgency for the relevant limit values.
Keywords: Fumigants, Methyl bromide, Ethylene oxide, Hemoglobin adducts, Past exposure, Transit goods and
production parts, Off gassing, Human biomonitoringBackground
As a part of a global economy, an international network
of suppliers, producers and retailers spans the world
with logistics companies which connect the vast under-
lying commodities and the labor market [1]. Diverse
interconnected companies and industries influence the
logistics and transportation job market [1]. With the
globalized production, most small and large companies* Correspondence: L.Budnik@uke.de
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unless otherwise stated.import production parts, raw materials or goods from
anywhere in the world. To ensure the preservation and
quality of the goods, chemical agents for pest control
have to be added to the goods or into the transport units.
Thus a possible exposure to these toxic chemicals may
occur not only for the applicators but also the receiver by
off gassing from products, packing materials or transport
units like containers. The international standards of the
UN Food and Agriculture Organization (FAO) for phyto-
sanitary measures (ISPM 15) require fumigation with
methyl bromide (or heat treatment) of wooden packaging
and flooring material (for pest control, i.e. spreading of
alien species). Methyl bromide is a broad spectrumhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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of pests (e.g. used for pre-plant soil preparation), wood
construction parts and for phytosanitary demands in ship-
ping and storage [2-4]. Besides its desirable properties
for pest control it also has ozone-depleting potency and
was therefore banned in the Montreal Protocol in 2005.
Nevertheless its usage is still allowed under the aus-
pices of a critical use exemptions (CUE) wherever an
adequate alternative is not available [3]. The fumigation
of transport units or some agricultural applications is
part of the CUEs. Due to the CUE more than 1,750 tons
of methyl bromide were applied only in the agricultural
sector of the State California in 2010 [5]. Additionally,
other pesticides based on halo-alkenes, like ethylene
dichloride, methyl chloride, propylene dichloride and
chloropicrin are frequently used fumigants; small propor-
tions are tainted with the methyl bromide substitutes
sulphuryl difluoride, methyl iodide or ethylene oxide [6-8].
Several cases of intoxication after exposure to halogenated
hydrocarbon pesticides, like methyl bromide or ethylene
dichloride, have been observed. In a recent study methyl
bromide exposure could be confirmed in 20% of the
cases out of 164 patients with presumed intoxication from
contact with halogenated hydrocarbon based fumigants
[6]. Ambient-monitoring measurements performed on
approx. 4,000 import containers in the harbors of
Hamburg and Rotterdam revealed that less than three
percent of the fumigated containers were labeled accord-
ing to an international regulation [7-9]. Consequently, if
no control measures are performed and the fumigation
history is unknown, those dealing with fumigated items
might be accidentally exposed and occasional intoxica-
tions may remain unrecognized. To some extent the
symptoms caused by these fumigants are similar [3,10-12].
Cases described in the literature show that the first clinical
symptoms of methyl bromide intoxication may be
unrecognized for up to three days resembling the flu (even
in the most severe cases of intoxication with lethal
outcome) [3,13-15]. Exposure to the colorless, odorless,
highly toxic, gaseous methyl bromide can occur through
two primary routes: inhalation and dermal resorption [3].
Methyl bromide is neurotoxic and leads to damages in the
central and peripheral nervous system, but also in the
respiratory system, kidney, liver and eyes [3,4]. Moreover
some indications for a carcinogenic property of methyl
bromide exist [3,16-18].
Here, we report a series of three accidents of six
storage room workers that occurred from 2010 to 2012;
a follow up was performed in 2013. Though we are
aware of many similar incidents across Europe [19],
hardly any case is published in the scientific literature.
On the other hand, insurance reports (confidential) or
press releases document mysterious sudden illness by




In a company, which received products from oversea,
several employees developed signs of intoxication. The
cases were submitted to one of us to consider a diagno-
sis of occupational disease and he escalated a toxico-
logical supervision of the cases (Table 1). Six storage
room workers were exposed to fumigants off gassing
from shifted items in a medium sized European com-
pany importing electronic construction parts from
overseas (Table 1). The exposures occurred three times
within two years. The patients were working in a storage
room. They were unloading ca. two overseas shipments
a week at the time of the incidence. All patients worked
8 hours each working day in a storage room, where
patients 1,3,4,5 and 6 unloaded the delivered items on a
regular basis, unpacked wooden pellets with paper boxes
covered with plastic (containing construction parts) and
distributed the construction parts for the production
line. Patient 2 supervised the working place. The deliv-
ered production parts were packed in several boxes on
wooden pellets wrapped with plastic foils. The workers
were responsible for unloading and distributing the
delivered items into several separate areas on several
different floors. After each incident the workers (patients
1, 3, 4, 5 and 6) noticed itchy skin, very red eyes and
suffered from recurrent epistaxis, headaches and acro-
taxia (intention tremor). After the second accident, four
individuals (Pat. 1, 3, 4 and 5) additionally complained
about paresthesia (pins and needles in the legs), dizzi-
ness, breathing difficulties and increasing irritability.
After the third accident, patient 4 was on sick leave for
several weeks; patients 1 and 3 developed immediate
epistaxis with a severe headache.
Sampling
First accident: an industrial physician took blood sam-
ples 48 hours after the first incidence and five days after.
Air samples were taken in the space between the delivered
boxes. Three months later, a second accident occurred
involving the same employees (Table 1). At this time
blood samples were taken for a head-space analysis (whole
blood); additional serum and hemoglobin were fraction-
ated (for details see below). The samples were taken
111 days after the second accident. At the third incident
(second biomonitoring), the samples were collected five
days after the accident; the third biomonitoring (follow
up) was initiated 178 days after the third accident. After
the third incident, additional measurements of methyl
mercapturic acid derivatives (MeMA) in urine were
performed.
Table 1 Case description and demographic data
Accidental occurrence Six storage room workers were exposed to fumigants off gassing from shifted items in a medium sized European
company importing electronic construction parts from Mexico and China. The exposures occurred three times
(2010-2012), as reported by the patients. 48 hours after the first incidence a contracted industrial physician took
blood samples and sent them to the clinical chemistry laboratory (Serum/EDTA blood, NaF blood) and sent
samples to the commercial clinical chemistry laboratory to investigate intoxication parameters. Since no other
information was provided to the laboratory, only a differential blood analysis was performed, no bromide,methyl
bromide or other intoxication parameters were measured. As usual in such a case the blood samples were
destroyed. Since two patients had persistent symptoms, the governmental industrial hygienist visited the company.
He took air samples in the space between the delivered boxes; the laboratory analysis revealed 2.5-200 ppm
residual methyl bromide. One year later, a second accident occurred involving the same employees. Ambient
monitoring was performed, which showed the presence of methyl bromide and ethylene oxide in the air. Five
days after the accident samples for biomonitoring (BM 2) were collected.
The time line of the three
accidents in the storage room
The accidents occurred between 2010 and 2012. For the BM No. 1, the samples were taken 195 days after the
first and 111 days after the second accident. For the BM No. 2, the biomonitoring samples were collected five
days after the third accident; BM No 3. (follow up) was initiated 178 days after the third accident (2013).
Exposure associated
job description
Exposed individuals: Patients 1-6 (aged: 32-54; 4 f, 2 m)
Patient 1 (47, f); patient 2 (32,m); patient 3 (39, f); patient 4 (41,m); patient 5 (54, f); patient 6 (38, f).
All patients worked 8 hours each working day in a storage space where patients 1,3,4,5 and 6 unloaded the
delivered items on a regular basis, unpacked wooden pellets with paper boxes covered with plastic
(containing with construction parts) and distributed the construction parts for the production line.
Patient 2 supervised the working place.
Exposures associated
symptoms
After each incident the workers (patients 1, 3, 4, 5 and 6) noticed itchy skin, very red eyes and suffered from
recurrent epistaxis, headaches and acrotaxia. After the second accident four individuals (Pat. 1, 3, 4 and 5)
additionally complained about paresthesia (pins and needles in the legs), dizziness, breathing difficulties and
increasing irritability. After the third accident, patient 4 was on sick leave for several weeks; patients 1 and 3
developed immediate epistaxis with a severe headache.
Description of the workplace Workplace: Medium sized company, which recently turned into a worldwide operating logistics unit with
production and distribution centers, but no internal industrial hygiene unit. The 6 patients were working in a
storage room. They were unloading ca. 2 overseas containers per week at the time of the incidence. According
to the interviews the containers were not labeled for fumigants; No air monitoring was performed on a regular
basis, though the workers sometimes perceived strange odors. The delivered production parts were packed in
several boxes on wooden pellets wrapped with a plastic foil. The workers were responsible for unloading and
distributing the delivered items into several separate areas on several different floors.
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Patients (n = 6, aged from 32–54 yrs.) and control group
(n = 30, with median age of 40 yrs.). Patients underwent
standardized medical examination for the symptoms of
fumigant intoxication as described earlier [10,11,19] and
donated blood and urine samples. Both, patients and the
control reference group, gave written permission. The
study was approved by the local ethics committee (PV
3597 to XB/LTB). The clinical examination was indica-
tive in the course of the social security case examination.
The questionnaire (Fum-Ex2) is published [6] and avail-
able online at: http://eomsociety.org/attachments/FUM-
EX%202_%20QUESTIONNAIRE_EOM%20ENGLISH%
20VERSION.pdf. Fum-Ex 2 records time, duration and
situation of exposure/s, applied protective devices and acute
and chronic symptoms related/not related to exposure/s. For a
complete diagnosis the job history is followed by a physical
examination and functional tests of probably affected organs
such as lung function testing, blood analyses, neurological and
neuropsychological investigations [19], for details see below.
Diagnostic scheme
 Occupational case history, FUM-EX2 questionnaire
(headache, dizziness, concentration disorders,increased desire to sleep, emotional irritability,
asthma, etc.)
 Lung function diagnostics (spirometry, methacholine
challenge test, exercise test with blood gas analysis,
CO diffusing capacity)
 Clinical Chemistry: Blood tests for liver enzymes,
bromide and fluoride in serum and urine
 Biomonitoring (see part “human biomonitoring
analysis” for details)
 Physical performance (grooved pegboard and finger
tapping test)
 Olfactory test (scented sticks)
 Color vision test (Farnsworth)
 Specific neurological and neuropsychological tests:
○ Test of crystallized and fluid intelligence
(multiple choice-vocabulary-intelligence test,
MWT-A, short test of general intelligence,
KAI)
○ Comprehensive neurological and
neuropsychological tests covering orientation,
information processing speed, selective
attention/concentration tests, divided attention,
sustained attention/vigilance, learning/memory
tests, spatial-construction ability, logical thinking
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verbal intelligence
 Magnetic resonance tomography, MRT, and cranial
computed tomography, c-CT, were done, if the before
mentioned non-invasive diagnostic tests showed
abnormal findings which may be due to cerebral
lesions
Additionally we analyzed blood and urine samples of
30 healthy (smoking and non-smoking) control persons
matching sex and age distribution to the patient group
plus one additional sample from a heavy smoker (used
as internal laboratory method control).
Ambient monitoring
Five days after the first accident and after the third inci-
dent, air samples were taken in the storage room where
the goods had been unpacked. These ambient monitor-
ing measurements were conducted and performed by
the local governmental industrial hygienist on duty. Me-
thyl bromide and ethylene oxide were measured using
the Selected Ion Flow Tube Mass Spectrometry method
[8]. Additionally, several days after the third incident, air
samples were also taken by the company’s engineer in
the storage rooms. They were analyzed with a validated
TD-GCMS method [20]. We have analyzed these air
samples three times between the second and third acci-
dent in the same storage room and could not find any
fumigant residues (data not shown). The samples were
taken with an interval of ca. one month. The limitation
however is that they were taken by the company’s engin-
eer (only) in the middle of the closed storage facilities
(not in the breathing zone).
Human biomonitoring analyses
Fumigants and their derivatives were measured in blood
samples (whole blood, serum) as follows: the substances
were detected by gas chromatography/mass spectrometry
(GCMS) (head space) in SIM mode in 60 m dimethyl-
polysiloxane DB1 capillary column under helium and
temperature program 40–250°C. The analysis included
the detection of methyl bromide (m/z 94, 79, 96), ethylene
dichloride (m/z 62, 49, 98), methyl dichloride (m/z 84, 49,
86) ethylene oxide (m/z 29, 43), methyl iodine (m/z 142,
127 and chloropicrin/trichloro-nitro-methane (m/z 119,
117, 83) in blood. Methyl bromide could be detected at
0.19 μg/L (RT peak at 7.5 min) and quantitated at
0.56 μg/L and ethylene oxide (RT peak at 7.3 min) with
a detection limit of 0.28 μg/L, a quantitation limit of
0.84 μg/L (as estimated with DIN 32645 method).
Bromide ion was detected using the photometric method
as described previously [21]. Long term biological exposure
effects were determined by measuring reaction products
(adducts) with macromolecules in blood, such as thehemoglobin (Hb) adducts N-methylvaline (MEV) and N-2-
hydroxyethylvaline (HEV) as described previously [6]. The
method is based on the N-alkyl Edman degradation
[22,23]. Due to controlling the influence of smoking on
the Hb adducts levels, the Hb adduct N-2-cyanoethylvalin
(CEV) was determined in addition to MEV and HEV by
the procedure as well. Moreover, the current smoking
status was objectivized by the determination of cotinine in
urine using a GC-MS-method [24]. Creatinine was deter-
mined using a HPLC method described elsewhere [24].
Parallel to the sensitivity of the hemoglobin adduct,
MEV-Assay was explored with the ROC (receiver oper-
ating characteristic) analysis, showing 70% sensitivity
and 75% specificity by a cut off value of 483 pmol/g
globin (AUC, Area Under Curve, values of 0.755) for
the MEV measurement and 90% sensitivity and 35%
specificity for the HEV analysis with a cut off value of
34 pmol/g globin (AUC = 0.550).
Mercapturic acids, derived from the chemical agents,
were measured in urine using offline and online solid
phase extraction of the analytes, respectively, with subse-
quent analytical separation and detection using LC-MS/
MS as described elsewhere [25,26]. 8-OHdG was deter-
mined with an enzyme-linked immunoabsorbent assay
provided by JaICA’s [6]. The measurements of circulating
mtDNA were described earlier [6]. All analytical methods
were validated using inter- and extra laboratory quality
assessment schemes from the German Society for Occu-
pational and Environmental Medicine (G-EQUAS).
Calculations of initial exposure levels and statistic
The elimination kinetics of the hemoglobin adduct level
follows the equation y = −0.81 x (days post-exposure) +
95 within the first 120 days (= average life-span of eryth-
rocytes) after exposure and with “y” as the percentage of
the initial adduct concentration after a single exposure,
as described by Bader [27,28]. Assuming that we were
dealing with individual, singular exposure, this equation
allows us to approximate the theoretical initial ethylene
oxide and methyl bromide levels at the time of exposure
for the individual patients. Notably, the Commission for the
Investigation of Health Hazards of Chemical Compounds
in the Work Area of the Deutsche Forschungsgemeinschaft,
DFG (German research council) provides equivalent values
(EKA correlation) for carcinogenic substances. The EKA
value correlates 1 ppm (1.83 mg/m3) ethylene oxide in the
air with 90 μg HEV per L blood [29]. Based on these bio-
logical exposure equivalents, the smoking coefficients (for
individual patients) and the elimination kinetics equation,
we have calculated the theoretical individual exposure-
associated MEV adduct values at the time of the exposure.
All methods were routinely validated with control serum
samples and additional standard set points (two analytic
standards, one low and one high concentration were used
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tion of the difference. The data analyses were performed
with Graph PAD Prism Software 6.0 (Graph Pad Software
Inc., San Diego, CA).Results
Ambient monitoring
The workplace and the details on the incidence and
sampling are described in Table 1. The air measurement
verified a methyl bromide concentration from 2.5 to
200 ppm (mean: 125 ppm with 2.5-200 ppm min-max) in
the storage room between the packing materials five days
after the incidence. After the third accident, 15 ppm ethyl-
ene oxide could be detected in the storage room. The air
samples were taken in the space between the packed elec-
tronic parts with trapped gas residues (in the breathing
zone of the workers). Considering that both, ethylene
oxide and methyl bromide, are extremely volatile, the con-
centrations of the fumigants in the air, on the day of the
individual incidence, were presumable at least four to five
times higher.Biological exposure monitoring
The fumigant levels in blood samples and the amounts
of bromide ion in serum are shown in Table 2. We did
not detect significantly elevated bromide levels in any of
the analyzed serum samples. However, we detected low
methyl bromide levels (0.24 μg/L) in the blood of patient
5 collected five days after the second incidence (BM2).
No increased levels of either ethylene dichloride, chloro-
picrin, methyl iodine or dichloromethane were detected
in the blood samples (all were < LOD). Patients 1, 3, 4, 5
and 6 showed slightly increased levels of ethylene oxide
in blood and two patients displayed elevated methanol







BM1 BM2 BM1 BM2 BM2
1 2.8 5.7 <LOD <LOD 5.06
2 2.5 4.3 <LOD <LOD <LOD
3 2.8 5.2 <LOD <LOD 5.96 <
4 1.7 4.8 <LOD <LOD 3.00 <
5 4.3 4.9 <LOD 0.241 0.57
6 3.1 4.4 <LOD <LOD 6.17
Con. 3.8 <LOD <LOD <LOD
Ref. 5 n.d. n.d. n.d.
The data show measurements of bromide (serum) and methyl bromide, ethylene o
samples. The bold data, indicate for values higher than the references. For details s
Con. = controls (n = 30); n.d. not determined; Ref. DFG = reference values available fSlightly elevated levels of MeMA were detected in the
urine sample of patient 1 only after the third incident
(data not shown).
The results for MEV, HEV, CEV and cotinine are given
in Table 3. The results for MEV and HEV were com-
pared to reference values for the German general popu-
lation considering the smoking status. The results
revealed elevated levels of MEV and HEV for patient 4
by the factor of 1.9 and 2.3, respectively, for patient 5 by
the factor of 1.7 and 1.4, respectively, and for patient 3
by the factor of 1.4 (MEV). Patient 5 had remarkably
high hemoglobin adduct levels at BM 2. Moreover,
patient 3 had higher MEV and HEV levels in BM 3.
Patients 1, 2 and 6 were in the expected range of smoker
or non-smoker at the time of sampling (shown in
Table 3). We have calculated (for details see Methods)
the theoretical individual exposure-associated (Figure 1)
MEV adduct values at the time of the exposure with
1,616 pmol/ g globin for patient 3, 1,880 pmol/g globin
for patient 4 and 1,640 pmol for patient 5 (after the me-
thyl bromide exposure). The respective HEV values
were: 1,403 pmol/ g globin for patient 3 (which correlate
with inhaled 0.4 ppm ethylene oxide); for patient 4 5,049
pmol/globin (correlating with 1.5 ppm inhaled ethylene
oxide) for patient 4 and 1,467 pmol/ g globin (correlat-
ing with 0.4 pmol ethylene oxide in the air) for patient 5.
Biological effect monitoring
After the third incident, biological effect biomarkers
were additionally measured (Table 4). Increased 8-OHdG
levels (as a short term marker for oxidative stress) were
observed in urine samples of patient 3 (142% increase vs.
the references), patient 4 (147% increased levels) and in
patient 5 (207% increase). When measuring the levels
of the circulating mitochondrial DNA, as a non-specific
effect toxicity biomarker [6], elevated levels could be







BM2 BM2 BM1 BM2 BM1 BM2
<LOD <LOD <LOD <LOD <LOD <LOD
<LOD <LOD <LOD <LOD 5.73 <LOD
LOD <LOD 0.51 <LOD <LOD <LOD
LOD <LOD <LOD 0.95 <LOD <LOD
<LOD <LOD <LOD <LOD <LOD <LOD
<LOD <LOD <LOD <LOD 0.67 <LOD
<LOD <LOD <LOD <LOD <LOD <LOD
n.d. n.d. n.d. n.d.
xide, ethylene dichloride, dichloromethane and methanol in whole blood
ee Methods.
rom the Senate Commission of the German Research Council [DFG, 2012].
Table 3 Biomonitoring for hemoglobin adducts MEV, HEV and CEV as well as for cotinine: BM1; BM2, BM3
Pat. MEV [pmol/g globin] HEV [pmol/g globin] CEV [pmol/g globin] Cotinine [μg/g Crea.]
BM1 BM2 BM3 BM1 BM2 BM3 BM1 BM2 BM3 BM1 BM2 BM3
1 453 447 -2 26 46 -2 01 01 -2 1 01 -2
2 485 476 -2 36 34 -2 01 01 -2 2 8 -2
3 546 388 -2 132 54 -2 70 31 -2 1469 1169 -2
4 726 652 656 350 348 509 162 150 245 5049 3894 2902
5 518 653 609 140 212 266 26 62 91 196 1182 1390
6 450 459 -2 115 107 -2 48 46 -2 1404 1409 -2
Con. NS 452 NS 43 NS <2 NS < 10/
S 539 S 132 S150 S >100
Ref. NS 320 NS < 75 NS <20 NS < 10/
S 390 S 150 S 150 S >100
1under limit of detection, 2samples not provided. The bold data, indicate for values higher than the references. For details see Methods.
Con. = mean controls values (n = 30); n.d. not determined; Ref. = mean DFG reference values available from the Senate Commission of the German Research
Council [DFG, 2012]. NS = non smoker, S = smoker.
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chondrial DNA in serum after the third intoxication
(Table 4).
Discussion
Here, we report a series of accidents of six storage room
workers in a medium sized European company regularly
importing electronic production parts from abroad. Three
out of four persons with presumed exposure showed ser-
ious intoxication symptoms with itchy skin, very red eyes,
dizziness, breathing difficulties and increasing irritability.
They suffered from recurrent epistaxis, headaches and
acrotaxia (intension tremor) with paresthesia (pins and
needles in the legs) and developed immediate epistaxis
with a severe headache. Since the ambient monitoring of
air samples was taken five days after the accident, the
initial fumigant concentration in the air at the time of the
incident was presumably at least four to five times higher
than the measured values. A correct strategy for the
human biomonitoring sampling time in the reported casesFigure 1 Theoretical HEV and MEV hemoglobin adduct levels at the time
respectively. All values were adjusted to smoking status using MEV/CEV and Hshould be one to three days post exposure, in order to
detect fumigant levels in blood (biological exposure moni-
toring). Unfortunately, this was not the case, besides a
discrete enhancement of ethylene oxide levels in some
patients. Given the published half-life of bromide in serum
with 10–12 days ca. 0.25% should be cleared after five days
(BM2). Though our reference group has median bromide
levels of 3.8 μg/L and our internal method-lab controls
(n = 50 unexposed) show a median value of 3.1 μg/L,
the values near the background levels do not allow any
extrapolation. We detected a low methyl bromide level
(0.24 μg/L) in the blood of patient 5, collected five days
after the second incidence (BM2), which might indicate
the incorporation at the day of the incidence. Only one
study shows human kinetics data on methyl bromide
levels in blood, with the elimination kinetics for up to
21 days after a fatal accident [15]. Little human literature
data indicate that both, methyl bromide and ethylene
oxide, have longer half lives in humans than in experimen-
tal animals with 12–99 h for ethylene oxide and up toof the individual exposure to ethylene oxide and methyl bromide,
EV/CEV coefficients. The data was modeled as described in the results part.








Pat.1 6.2 32.3 2.42
Pat.2 4.6 14.5 0.40
Pat.3 9.8 796.5 1.34
Pat.4 10.2 26.2 1.35
Pat.5 14.3 147.8 1.43
Pat.6 12.9 86.9 0.41
Con. 6.7 0.08
Ref. n.d. n.d. 0.5-3.0
Human biomonitoring (BM2) measurements were performed in samples
collected five days after the third accident. The data show measurements of
8-OHdG as well as the circulating mitochondrial DNA (mtDNA79). The bold data,
indicate for values higher than the references.
The controls (con.) represent median values from 30 non-exposed individuals
measured in the same analytical step as the patient samples.
n.d. not determined; Ref. = DFG = reference values available from the Senate
Commission of the German Research Council [DFG, 2012].
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exposure circumstances and genetic predispositions)
[15,30,31].
No reference values exist for methyl bromide (how-
ever, since the data from the control groups show values
below the limit of detection, we assume that there is no
general background contamination).Though there is a
weak indication for the presence of fumigants in blood
(2 patients), these exposure biomonitoring data do not
allow any firm interpretation The half-life of mercapturic
acids, MeMA is with 12–48 h extremely short, only
allowing the detection of immediate exposure/s.
In-vivo dose monitoring by means of adducts to mac-
romolecules after exposure to methylating agents has
been well characterized earlier [23]. Ethylene oxide is
known to alkylate (2-hydroxylate) cellular macromole-
cules including proteins and DNA. Methyl bromide is an
established methylating agent. The hemoglobin adducts
methyl valine and hydroxyl ethyl valine are biochemical
effect markers, elevated after exposure to alkylating che-
micals like methyl bromide or ethylene oxide. MEV and
HEV in particular are adducts of methylating agents
formed on the N-terminal valine of hemoglobin [32,33].
Hemoglobin adducts: N- (2-hydroxyl ethyl valine), HEV
and 2-methylvaline, MEV have been used as a molecular
dosimeter for exposure to ethylene oxide and methylating
agents, respectively [34]. The monitoring of hemoglobin
adducts additionally allows to monitor past exposure and
to generate extrapolated data that might improve the risk
assessment strategy. Bader and his colleagues [27,28]
proved that hemoglobin adduct levels can be used for
monitoring single accidental exposures in case of an
industrial accident. They provided a mathematical model
allowing the extrapolation of the data. We herebycalculated the theoretical exposure/s to methyl bromide
and ethylene oxide at the time of the individual incidents.
Based on this data, the intoxication could be confirmed
for three patients out of six (patients, 3, 4 and 5); data for
patients 1, 2 and 6 did not allow any extrapolation. Con-
sidering the suggested German acceptance limit values
with 0.1 ppm and the tolerance limit values of 1 ppm for
ethylene oxide, it appears that the patients 3, 4 and 5 were
exposed to fumigant levels higher than the acceptable
values (0. 1 ppm). An enhancement of the tolerable expos-
ure level (1 ppm) could be extrapolated for patient 4.
Currently no biological equivalent values are available for
methyl bromide. Considering the current limit values of
1 ppm for methyl bromide, we could presume the expos-
ure/s above the tolerable fumigant levels for all three
patients 3, 4 and 5. The clinical examination data from
these patients (data not shown here) also support the evi-
dence of intoxication. No intoxication could be confirmed
for patients 1, 2 and 6. Patient 2 was supervising the rest
of the crew and patients 1and 6 were mostly engaged in
other areas of the storage room after the first incidence
having less direct contact with (newly delivered) unloaded
products. Notably, after the first accident the company
reorganized the storage area with a separate zone for
unpacking the incoming shipment. As reported, the pa-
tients showed serious intoxication symptoms with itchy
skin, very red eyes, dizziness, breathing difficulties and
increasing irritability. They suffered from recurrent epi-
staxis, headache, acrotaxia, (intention tremor) paresthesia,
and/or developed immediate epistaxis. It is important
to note that the symptoms of acute methyl bromide
intoxication comprise irritation of mucosa, nausea, head-
ache, vision disorders, apraxia and acrotaxia [10,11,19],
neuropathy [13], encephalopathy [35,36], paresthesia [37]
or even death [14,15].
Our case studies indicate a need for an early and com-
prehensive prevention system including dedicated rules
for the occupational hygiene and biomonitoring proce-
dures. Most of the transport units (either unopened con-
tainer or plastic covered pellets) are commonly unpacked
outside the harbor areas and not at the border. Intoxica-
tion incidents reported herewith occur in many small
European companies [19] and can presumably happen in
any country of the globalized world.
Limitations
There are several limitations. First of all, the calculation
performed was based on the assumption that we are
dealing with single exposures as reported to the govern-
mental industrial physician and the insurance company.
The intermediate exposure/s (between the reported acci-
dents) is likely causing cumulative accumulation of adducts
in blood. Markedly, we could not detect fumigants on three
randomly chosen control air measurements (data not
Kloth et al. Environmental Health 2014, 13:110 Page 8 of 9
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of the patients: we had to consider individual adduct levels
caused by smoking.
Though the measurement of adducts as a biomarker of
exposure is several orders of magnitude more sensitive
than disease epidemiological investigations [38], an adduct
formation from endogenously produced ethane with S-
adenosylmethionine as the reactive product have been
documented [23,39]. To a small extent, ethane present
in urban pollution can enhance basal HEV levels [39].
Variations of MEV and HEV levels are partly hereditary
especially with respect to a glutathione S-transferase
catalyzed metabolism [40], while suggested dietary meat
consumption has no effect on MEV or HEV levels [41].
Törnqvist and her colleagues have documented back-
ground (non-occupational) adduct levels with 16 [9-38]
pmol/g globin for HEV and 225 [217–372] pmol/g globin
for MEV, in non-smoking subjects [22,40]. However, it has
to be mentioned that hemoglobin adduct levels need
several weeks for reaching steady-state. Thus, only high
accidental exposure can produce a detectable impact on
Hb adduct levels.
The biological effect markers mitochondrial DNA and
8-OhDG confirm possible past intoxication with toxic/
carcinogenic chemicals, however provide no additional in-
formation related to individual incidents. Notably, patients
3, 4 and 5 showed persistent neurological symptoms one
year after the incidents. Possible long term effects should
not be underestimated, since ethylene oxide and methyl
bromide are presumably carcinogenic to humans [3,34].
Conclusions
The data emphasize that there is a lack of knowledge on
risk assessment and monitoring strategies for incident
scenarios. The cases reported here, stress the importance of
the human biomonitoring guidelines for occasional expos-
ure to toxic substances. They should provide necessary
information to the industrial physicians on how to choose
the required biomarker, the adequate matrix and the sam-
pling time. The guidelines must put a strong emphasis on
an immediate contact with a qualified laboratory directly
after the intoxication to get adequate biomonitoring
support. At workplaces in the country sites, sufficient
awareness is still needed on possible risks from fumigants.
Unfamiliarity with possible risks due to gas emissions leave
many persisting intoxication cases unrecognized.
The international regulatory bodies should reconsider if
there is a phytosanitary need for fumigation of transport
units containing electronic construction parts.
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